533 related articles for article (PubMed ID: 17020977)
21. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
Burgos JS; Vera-Sempere FJ
Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
[TBL] [Abstract][Full Text] [Related]
23. Relationship between EBV infection and expression of cellular proteins c-Myc, Bcl-2, and Bax in gastric carcinomas.
Lima MA; Ferreira MV; Barros MA; Pardini MI; Ferrasi AC; Mota RM; Rabenhorst SH
Diagn Mol Pathol; 2008 Jun; 17(2):82-9. PubMed ID: 18382371
[TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential.
Cheung FM; Pang SW; Yau TK; Chow SK; Lo KW
Histopathology; 2004 Aug; 45(2):171-9. PubMed ID: 15279636
[TBL] [Abstract][Full Text] [Related]
25. Pretherapy quantitative measurement of circulating Epstein-Barr virus DNA is predictive of posttherapy distant failure in patients with early-stage nasopharyngeal carcinoma of undifferentiated type.
Leung SF; Chan AT; Zee B; Ma B; Chan LY; Johnson PJ; Lo YM
Cancer; 2003 Jul; 98(2):288-91. PubMed ID: 12872347
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 and proliferating cell nuclear antigen (PCNA) expression correlates with subsequent local recurrence in nasopharyngeal carcinomas.
Tsai ST; Jin YT; Leung HW; Wang ST; Tsao CJ; Su IJ
Anticancer Res; 1998; 18(4B):2849-54. PubMed ID: 9713473
[TBL] [Abstract][Full Text] [Related]
27. [Expression of P53 and PCNA in nasopharyngeal carcinoma and their relation with clinical stage, VCA/IgA, EA/IgA, radiation sensibility, and pognosis].
Mo HY; Zhang CQ; Feng KT; Zhang F; Hong MH; Sun ZY
Ai Zheng; 2004 Nov; 23(11 Suppl):1551-4. PubMed ID: 15566678
[TBL] [Abstract][Full Text] [Related]
28. P53 overexpression and Epstein-Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas.
Niedobitek G; Agathanggelou A; Barber P; Smallman LA; Jones EL; Young LS
J Pathol; 1993 Aug; 170(4):457-61. PubMed ID: 8410495
[TBL] [Abstract][Full Text] [Related]
29. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
Homma A; Furuta Y; Oridate N; Nakano Y; Kohashi G; Yagi K; Nagahashi T; Yagi K; Nagahashi T; Fukuda S; Inoue K; Inuyama Y
Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus DNA, intermediate filaments and epithelial membrane antigen in nasopharyngeal carcinoma.
Friedrich RE; Bartel-Friedrich S; Lobeck H; Niedobitek G; Arps H
Anticancer Res; 2000; 20(6D):4909-16. PubMed ID: 11326639
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
33. Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.
Ho CH; Chen CL; Li WY; Chen CJ
Carcinogenesis; 2009 Aug; 30(8):1443-51. PubMed ID: 19483191
[TBL] [Abstract][Full Text] [Related]
34. Comparison of Epstein-Barr virus DNA level in plasma, peripheral blood cell and tumor tissue in nasopharyngeal carcinoma.
Shao JY; Zhang Y; Li YH; Gao HY; Feng HX; Wu QL; Cui NJ; Cheng G; Hu B; Hu LF; Ernberg I; Zeng YX
Anticancer Res; 2004; 24(6):4059-66. PubMed ID: 15736452
[TBL] [Abstract][Full Text] [Related]
35. Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck.
Yang HJ; Cho YJ; Kim HS; Chang MS; Sung MW; Kim WH
Head Neck; 2001 Aug; 23(8):629-36. PubMed ID: 11443745
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.
Xiang Y; Yao H; Wang S; Hong M; He J; Cao S; Min H; Song E; Guo X
Laryngoscope; 2006 Jan; 116(1):126-30. PubMed ID: 16481824
[TBL] [Abstract][Full Text] [Related]
37. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
Murono S; Yoshizaki T; Park CS; Furukawa M
Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
[TBL] [Abstract][Full Text] [Related]
38. Recombinant adeno-associated virus mediated RNA interference inhibits metastasis of nasopharyngeal cancer cells in vivo and in vitro by suppression of Epstein-Barr virus encoded LMP-1.
Li X; Liu X; Li CY; Ding Y; Chau D; Li G; Kung HF; Lin MC; Peng Y
Int J Oncol; 2006 Sep; 29(3):595-603. PubMed ID: 16865275
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
40. [Interaction between Epstein-Barr virus (EBV) gene expression and antibodies to EBV in nasopharyngeal carcinomas].
Furukawa M; Nagayama I; Murono S; Takeshita H; Nishimura T; Yoshizaki T
Rinsho Byori; 1996 Sep; 44(9):832-7. PubMed ID: 8911067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]